401
Views
39
CrossRef citations to date
0
Altmetric
Review

Lipid-lowering effects of statins: a comparative review

&
Pages 1701-1714 | Published online: 23 Aug 2006

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Pierre Vladimir Ennezat, Claire Vannesson, Nadia Bouabdallaoui, Sylvestre Maréchaux, Philippe Asseman & Thierry H LeJemtel. (2011) Imagine how many lives you save: angiotensin-converting enzyme inhibition for atherosclerotic vascular disease in the present era of risk reduction. Expert Opinion on Pharmacotherapy 12:6, pages 883-897.
Read now
Svetla Baykoucheva. (2010) Selecting a Database for Drug Literature Retrieval: A Comparison of MEDLINE, Scopus, and Web of Science. Science & Technology Libraries 29:4, pages 276-288.
Read now

Articles from other publishers (37)

Troy E. Zehnder, Daniel J. Nasrallah, Jarrod L. Stanley, John J. Kiernicki, Nathaniel K. Szymczak & Corinna S. Schindler. (2023) Development of an In Situ Protocol for the Intramolecular Olefination of Oximes. Organometallics 42:6, pages 479-485.
Crossref
Pavlína Horáková & Kamila Kočí. (2022) Continuous-Flow Chemistry and Photochemistry for Manufacturing of Active Pharmaceutical Ingredients. Molecules 27:23, pages 8536.
Crossref
T. M. H. Hoang, T. T. Luu, T. H. T. Ngo, T. M. H. Nguyen, H. G. Tran, T. T. O. Nguyen, V. M. Chau & Dang Diem Hong. (2022) Hypolipidaemic Effects of (24R)-4α-methyl-5α-stigmasta-7,22-dien-3β-ol Derived from Aurantiochytrium mangrovei BT3 in the HEPG2 Cell Line. Applied Biochemistry and Microbiology 58:3, pages 286-293.
Crossref
Daniel J. Nasrallah, Troy E. Zehnder, Jacob R. Ludwig, Daniel C. Steigerwald, John J. Kiernicki, Nathaniel K. Szymczak & Corinna S. Schindler. (2022) Hydrazone and Oxime Olefination via Ruthenium Alkylidenes. Angewandte Chemie International Edition 61:22.
Crossref
Daniel J. Nasrallah, Troy E. Zehnder, Jacob R. Ludwig, Daniel C. Steigerwald, John J. Kiernicki, Nathaniel K. Szymczak & Corinna S. Schindler. (2022) Hydrazone and Oxime Olefination via Ruthenium Alkylidenes. Angewandte Chemie 134:22.
Crossref
Vahid Sheikhhassani, Tom M. J. Evers, Sanjeevani Lamba, Fereshteh Shokri & Alireza Mashaghi. (2022) Single cell force spectroscopy of erythrocytes at physiological and febrile temperatures reveals mechano-modulatory effects of atorvastatin. Soft Matter 18:11, pages 2143-2148.
Crossref
Rajagopalan Ramaswamy, Soon Nan Wee, Kavya George, Abhijit Ghosh, Joydeep Sarkar, Rolf Burghaus & Jörg Lippert. (2021) CKD subpopulations defined by risk‐factors: A longitudinal analysis of electronic health records. CPT: Pharmacometrics & Systems Pharmacology 10:11, pages 1343-1356.
Crossref
Sophia L. Song, Sarah B. Hays, Constance E. Panton, Evangelia K. Mylona, Markos Kalligeros, Fadi Shehadeh & Eleftherios Mylonakis. (2020) Statin Use Is Associated with Decreased Risk of Invasive Mechanical Ventilation in COVID-19 Patients: A Preliminary Study. Pathogens 9:9, pages 759.
Crossref
Monika Yadav, Nicola Schiavone, Ana Guzman-Aranguez, Fabrizio Giansanti, Laura Papucci, Maria J. Perez de Lara, Mandeep Singh & Indu Pal Kaur. (2020) Atorvastatin-loaded solid lipid nanoparticles as eye drops: proposed treatment option for age-related macular degeneration (AMD). Drug Delivery and Translational Research 10:4, pages 919-944.
Crossref
Fabliha Ahmed Chowdhury, S. M. E. Al Baker, Mohammad Safiqul Islam, Noor Ahmed Nahid, Mir Abdullah Al Mamun, Md. Reazul Islam, Mohd Nazmul Hasan Apu, Zabun Nahar, Maizbha Uddin Ahmed & Abul Hasnat. (2019) Association between variants of COQ2 and TNF-α genes and statin-induced toxicities in Bangladeshi hyperlipidemic patients. Drugs & Therapy Perspectives 35:12, pages 621-626.
Crossref
Ilze Mentoor, A-M Engelbrecht & Theo Nell. (2019) Fatty acids: Adiposity and breast cancer chemotherapy, a bad synergy?. Prostaglandins, Leukotrienes and Essential Fatty Acids 140, pages 18-33.
Crossref
Colin H. Beckwitt, Adam Brufsky, Zoltán N. Oltvai & Alan Wells. (2018) Statin drugs to reduce breast cancer recurrence and mortality. Breast Cancer Research 20:1.
Crossref
Janani Balraj, Karunyadevi Jairaman, Vidhya Kalieswaran & Angayarkanni Jayaraman. (2018) Bioprospecting lovastatin production from a novel producer Cunninghamella blakesleeana. 3 Biotech 8:8.
Crossref
Young Hee Lee, Mayavan Viji, Eunhwa Lee, Hyeju Jo, Kyung Yoo, Jaeuk Sim, Sunhwan Lee, Kiho Lee, Heesoon Lee & Jae-Kyung Jung. (2017) Synthesis and characterization of Rosuvastatin calcium impurity A; a HMG-CoA reductase inhibitor. Tetrahedron Letters 58:26, pages 2614-2617.
Crossref
Foukia E. Mouafi, Ghada S. Ibrahim & Mostafa M. Abo Elsoud. (2016) Optimization of lovastatin production from Aspergillus fumigatus. Journal of Genetic Engineering and Biotechnology 14:2, pages 253-259.
Crossref
Noton K. Dutta, Natalie Bruiners, Michael L. Pinn, Matthew D. Zimmerman, Brendan Prideaux, Véronique Dartois, Maria L. Gennaro & Petros C. Karakousis. (2016) Statin adjunctive therapy shortens the duration of TB treatment in mice. Journal of Antimicrobial Chemotherapy 71:6, pages 1570-1577.
Crossref
Gisle Langslet. (2016) Replacing statins with PCSK9-inhibitors and delaying treatment until 18 years of age in patients with familial hypercholesterolaemia is not a good idea. European Heart Journal 37:17, pages 1357-1359.
Crossref
Damjan Šterk, Werner Zaugg, Ulrich Beutler, Eric M. Loeser, Kapa Prasad & Zdenko Časar. (2016) Efficient and highly stereoselective assembly of rosuvastatin. Tetrahedron Letters 57:12, pages 1338-1341.
Crossref
Juan Tamargo, José M. Castellano & Valentín Fuster. (2015) The Fuster-CNIC-Ferrer Cardiovascular Polypill: a polypill for secondary cardiovascular prevention. International Journal of Cardiology 201, pages S15-S23.
Crossref
Stefano Tartaggia, Clark Ferrari, Marta Pontini & Ottorino De Lucchi. (2015) A Practical Synthesis of Rosuvastatin and Other Statin Intermediates. European Journal of Organic Chemistry 2015:19, pages 4102-4107.
Crossref
Joseph P. Kitzmiller, Jasmine A. Luzum, Damiano Baldassarre, Ronald M. Krauss & Marisa W. Medina. (2014) CYP3A4*22 and CYP3A5*3 are associated with increased levels of plasma simvastatin concentrations in the cholesterol and pharmacogenetics study cohort. Pharmacogenetics and Genomics 24:10, pages 486-491.
Crossref
Tadeja Vajdič, Matej Ošlaj, Gregor Kopitar & Peter Mrak. (2014) Engineered, highly productive biosynthesis of artificial, lactonized statin side-chain building blocks: The hidden potential of Escherichia coli unleashed. Metabolic Engineering 24, pages 160-172.
Crossref
Jian Li, Hongni Wang, Li Liu & Jiangtao Sun. (2014) Metal-free, visible-light photoredox catalysis: transformation of arylmethyl bromides to alcohols and aldehydes. RSC Adv. 4:91, pages 49974-49978.
Crossref
Damjan Šterk, Marko Jukič & Zdenko Časar. (2013) Application of Flow Photochemical Bromination in the Synthesis of a 5-Bromomethylpyrimidine Precursor of Rosuvastatin: Improvement of Productivity and Product Purity. Organic Process Research & Development 17:1, pages 145-151.
Crossref
Damjan Šterk, Zdenko Časar, Marko Jukič & Janez Košmrlj. (2012) Concise and highly efficient approach to three key pyrimidine precursors for rosuvastatin synthesis. Tetrahedron 68:9, pages 2155-2160.
Crossref
Weizheng Fan, Wanfang Li, Xin Ma, Xiaoming Tao, Xiaoming Li, Ying Yao, Xiaomin Xie & Zhaoguo Zhang. (2012) Acid-labile δ-ketal-β-hydroxy esters by asymmetric hydrogenation of corresponding δ-ketal-β-keto esters in the presence of CaCO3. Chemical Communications 48:35, pages 4247.
Crossref
Isao Fujii. (2010) Functional analysis of fungal polyketide biosynthesis genes. The Journal of Antibiotics 63:5, pages 207-218.
Crossref
James M. McKenney, Peter Ganz, Barbara S. Wiggins & Joseph S. Saseen. 2009. Clinical Lipidology. Clinical Lipidology 253 280 .
Jennifer G. Robinson. (2008) Is a statin as part of a polypill the answer?. Current Atherosclerosis Reports 11:1, pages 15-22.
Crossref
G. BirnbaumB. CreeI. AltafullahM. ZinserA. T. Reder. (2008) Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis. Neurology 71:18, pages 1390-1395.
Crossref
Frederick F Samaha, James McKenney, LeAnne T Bloedon, William J Sasiela & Daniel J Rader. (2008) Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia. Nature Clinical Practice Cardiovascular Medicine 5:8, pages 497-505.
Crossref
Marie-Hélène Fouchet, Frédéric Donche, Christelle Martin, Anne Bouillot, Christophe Junot, Anne-Bénédicte Boullay, Florent Potvain, Sylvie Demaria Magny, Hervé Coste, Max Walker, Marc Issandou & Nérina Dodic. (2008) Design and evaluation of a novel series of 2,3-oxidosqualene cyclase inhibitors with low systemic exposure, relationship between pharmacokinetic properties and ocular toxicity. Bioorganic & Medicinal Chemistry 16:11, pages 6218-6232.
Crossref
Peter H. Jones & John A. Farmer. (2008) Adjunctive interventions in myocardial infarction: The role of statin therapy. Current Atherosclerosis Reports 10:2, pages 142-148.
Crossref
Jisun Oh, Matthew R Ban, Brooke A Miskie, Rebecca L Pollex & Robert A Hegele. (2007) Genetic determinants of statin intolerance. Lipids in Health and Disease 6:1.
Crossref
K. Wikhe, C. Westermeyer & I.G. Macreadie. (2007) Biological consequences of statins in Candida species and possible implications for human health . Biochemical Society Transactions 35:6, pages 1529-1532.
Crossref
Michael H. Davidson. (2007) Squalene synthase inhibition: A novel target for the management of dyslipidemia. Current Atherosclerosis Reports 9:1, pages 78-80.
Crossref
Michael H. Davidson. 2007. Therapeutic Lipidology. Therapeutic Lipidology 121 148 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.